This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Saturday, August 24, 2013
New Issue - Clinical Liver Disease: Liver Transplantation
Clinical Liver Disease: New Issue Now Available
August 2013
Volume 2, Issue 4
Pages 145–196
In the U.S., 7000 people per year receive a liver transplant, but thousands more wait for an organ to become available. This issue of Clinical Liver Disease (CLD), guest edited by Dr. Norah Terrault, explores the current topics and controversies in the field of liver transplantion, from refining the criteria used for selection, to managing infection before and after the operation.
Clinical Liver Disease (CLD) is the latest online learning resource of AASLD. Clinical in focus, CLD blends text, audio, video, webinars, and other interactive content into educational interventions launched every two months. These interventions are designed for any physician or healthcare provider caring for a patient with liver disease.
Selection for liver transplantation (pages 145–147)
Adam Peyton and Paul Martin
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.218
Abstract
Full Article (HTML)
PDF(380K)
MELD score, allocation, and distribution in the United States (pages 148–151)
Joel P. Wedd, Ann M. Harper and Scott W. Biggins
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.233
Abstract
Full Article (HTML)
PDF(506K)
Donor and recipient effects on graft and patient survival (pages 152–155)
JP Norvell and Josh Levitsky
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.223
Abstract
Full Article (HTML)
PDF(429K)
Expanding the donor pool in liver transplantation: Extended criteria donors (pages 156–159)
Andrew S. deLemos and Parsia A. Vagefi
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.222
Abstract
Full Article (HTML)
PDF(509K)
Current state of living donor liver transplantation (pages 160–164)
Paige M. Porret and Kim M. Olthoff
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.231
Abstract
Full Article (HTML)
PDF(570K)
Acute liver failure: Peritransplant management and outcomes (pages 165–168)
Oren K. Fix
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.219
Abstract
Full Article (HTML)
PDF(320K)
Hepatitis B virus: Prevention of recurrent infection (pages 169–172)
Federico G. Villamil and Fernando M. Cairo
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.224
Abstract
Full Article (HTML)
PDF(395K)
Hepatitis C virus: Antiviral therapy in wait-listed patients (pages 173–176)
Asmeen Bhatt and Gregory T. Everson
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.225
Abstract
Full Article (HTML)
PDF(412K)
Hepatitis C virus: Management of recurrent disease (pages 177–180)
Elizabeth C. Verna
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.220
Abstract
Full Article (HTML)
PDF(440K)
Common problems in liver allograft biopsy interpretation: Resolving clinical dilemmas (pages 181–187)
Oyedele A. Adeyi
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.229
Abstract
Full Article (HTML)
PDF(1528K)
Immunosuppression: Conventions and controversies (pages 188–191)
Neil Mehta and Ryutaro Hirose
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.221
Abstract
Full Article (HTML)
PDF(414K)
The liver transplant operation (pages 192–196)
Charles Miller and Teresa Diago Uso
Article first published online: 19 AUG 2013 | DOI: 10.1002/cld.232
Abstract
Full Article (HTML)
PDF(698K)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment